ProPhase Labs (PRPH) Return on Capital Employed [ROCE] (2011 - 2026)
ProPhase Labs (PRPH) recorded Return on Capital Employed [ROCE] of -479.87% in Q1 2026, down 373.56 percentage points from -106.31% a year earlier and down 293.93 percentage points from the prior quarter.
ProPhase Labs (PRPH) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends
For FY2025, ProPhase Labs reported Return on Capital Employed [ROCE] of -213.46%, down 128.43 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] has declined for three straight years, with a five-year change of -200.07 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Capital Employed [ROCE] came in at -85.03% in FY2024 (-54.25 pp), -30.78% in FY2023 (-63.38 pp), 32.59% in FY2022 (+10.73 pp) and 21.86% in FY2021 (+35.25 pp).
- The Q1 2026 figure is the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q3 2011.
- Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 59.34 percentage points in Q3 2022, against a drop of 373.56 percentage points in Q1 2026 at the low end.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | ProPhase Labs | 155,925.56 | -390,074.44 | 226,000.00 | - |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -479.87% |
| Dec 31, 2025 | -185.95% |
| Jun 30, 2025 | -153.19% |
| Mar 31, 2025 | -106.31% |
| Dec 31, 2024 | -85.14% |
| Sep 30, 2024 | -50.43% |
| Jun 30, 2024 | -50.59% |
| Mar 31, 2024 | -44.32% |
| Dec 31, 2023 | -29.90% |
| Sep 30, 2023 | -20.47% |
| Jun 30, 2023 | -8.70% |
| Mar 31, 2023 | 11.40% |
| Dec 31, 2022 | 30.77% |
| Sep 30, 2022 | 52.16% |
| Jun 30, 2022 | 44.79% |
| Mar 31, 2022 | 33.10% |
| Dec 31, 2021 | 14.98% |
| Sep 30, 2021 | -7.18% |
| Jun 30, 2021 | -2.33% |
| Mar 31, 2021 | -0.12% |
ProPhase Labs Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=PRPH&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "PRPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=PRPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();